112 related articles for article (PubMed ID: 24483847)
1. Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature.
Angioli R; Luvero D; Aloisi A; Capriglione S; Gennari P; Linciano F; Li Destri M; Scaletta G; Montera R; Plotti F
Expert Rev Anticancer Ther; 2014 Apr; 14(4):431-9. PubMed ID: 24483847
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
3. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
4. Critical review of neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer.
Colombo N; Peiretti M
Int J Gynecol Cancer; 2010 Oct; 20(11 Suppl 2):S47-8. PubMed ID: 21053527
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer.
Benedetti Panici P; Bellati F; Manci N; Pernice M; Plotti F; Di Donato V; Calcagno M; Zullo MA; Muzii L; Angioli R
Ann Surg Oncol; 2007 Sep; 14(9):2643-8. PubMed ID: 17562114
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer.
Behtash N; Nazari Z; Ayatollahi H; Modarres M; Ghaemmaghami F; Mousavi A
Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
8. Current approaches of neoadjuvant chemotherapy in cervical cancer.
Aoki Y; Tanaka K
Expert Rev Anticancer Ther; 2002 Feb; 2(1):73-82. PubMed ID: 12113071
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
Angioli R; Plotti F; Montera R; Aloisi A; Luvero D; Capriglione S; Terranova C; De Cicco Nardone C; Muzii L; Benedetti-Panici P
Gynecol Oncol; 2012 Nov; 127(2):290-6. PubMed ID: 22819938
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy and concurrent chemoradiotherapy followed by surgery for stage Ib-IIb cervical cancer: single institution experience.
Fröbe A; Jones G; Bokulić T; Mrčela I; Budanec M; Murgić J; Jakšić B; Prpić M; Bolanča A; Kusić Z
Anticancer Res; 2014 Jul; 34(7):3861-6. PubMed ID: 24982415
[TBL] [Abstract][Full Text] [Related]
13. Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy.
Lee JY; Kim YH; Kim MJ; Kim K; Chung HH; Park NH; Song YS; Kang SB
Arch Gynecol Obstet; 2011 Aug; 284(2):477-82. PubMed ID: 20878172
[TBL] [Abstract][Full Text] [Related]
14. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
Vizza E; Corrado G; Zanagnolo V; Tomaselli T; Cutillo G; Mancini E; Maggioni A
Gynecol Oncol; 2014 May; 133(2):180-5. PubMed ID: 24589412
[TBL] [Abstract][Full Text] [Related]
16. [The role of the preoperative radiochemotherapy and the role of neoadjuvant chemotherapy before radical Wertheim-Meigs hysterectomy for cervical cancer stage I B - II B].
Ivanov S; Kŭrlov A
Akush Ginekol (Sofiia); 2006; 45(2):28-31. PubMed ID: 16637300
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cervical cancer in Italy: strategies and their impact on the women.
De Vincenzo R; Amadio G; Ricci C; Licameli A; Ferrandina G; Capelli G; Scambia G
Vaccine; 2009 May; 27 Suppl 1():A39-45. PubMed ID: 19480960
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage IB2-IIA cervical cancer.
Prueksaritanond N; Chaisarn P; Yanaranop M
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S55-61. PubMed ID: 22619888
[TBL] [Abstract][Full Text] [Related]
20. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
